FdaApplication
BLA 761289
Identifiers
- fda_app_no: BLA761289
Properties
| Property | Value |
|---|---|
| applicant_name | AstraZeneca AB |
| application_type | BLA |
| approval_date | 2022-10-21 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IMJUDO | TREMELIMUMAB-ACTL | 25MG/1.25ML (20MG/ML) | Injection |
| IMJUDO | TREMELIMUMAB-ACTL | 300MG/15ML (20MG/ML) | Injection |
2 products